These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3127299)

  • 21. Chromosome abnormalities in the myelodysplastic syndromes.
    Heim S; Mitelman F
    Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent advances in the cytogenetics of malignant hemopathies].
    Berger R
    Sem Hop; 1981 Jan 18-25; 57(3-4):201-3. PubMed ID: 6261363
    [No Abstract]   [Full Text] [Related]  

  • 23. [Significance, diagnosis and prognosis in the cytogenetic analysis in acute leukemias and myelodysplastic syndromes].
    Jotterand Bellomo M
    Ther Umsch; 1996 Feb; 53(2):103-10. PubMed ID: 8629259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetics of myelodysplastic syndromes.
    Fenaux P; Morel P; Lai JL
    Semin Hematol; 1996 Apr; 33(2):127-38. PubMed ID: 8722683
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytogenetics of myelodysplastic syndromes.
    Mecucci C; La Starza R
    Forum (Genova); 1999; 9(1):4-13. PubMed ID: 10101207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chromosome aberrations in malignant blood diseases].
    Engel E; McKee LC; Engel-de Montmollin M
    Union Med Can; 1968 Jul; 97(7):901-6. PubMed ID: 5709532
    [No Abstract]   [Full Text] [Related]  

  • 27. Contemporary management of leukemia: cytogenetic diagnosis and monitoring of acute leukemia and preleukemia.
    Sandberg AA; Hecht F; McCaw BK
    Ariz Med; 1981 Dec; 38(12):906-11. PubMed ID: 7332496
    [No Abstract]   [Full Text] [Related]  

  • 28. Usefulness of cytogenetics in leukemias.
    VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
    Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical utility of cytogenetic analysis in acute leukemia.
    Carroll AJ; Finley WH
    Ala J Med Sci; 1985 Jan; 22(1):90-3. PubMed ID: 3977015
    [No Abstract]   [Full Text] [Related]  

  • 30. [The importance of cytogenetic examination in childhood malignancies].
    Goetz P; Stejskalová E; Starý J; Weinreb M; Hrodek O; Koutecký J
    Cesk Pediatr; 1990 Mar; 45(3):146-50. PubMed ID: 2282670
    [No Abstract]   [Full Text] [Related]  

  • 31. [Significance of WHO classification for acute leukemia and myelodysplastic syndrome].
    Sugiura A; Takeshita A
    Rinsho Byori; 2006 Nov; 54(11):1178-86. PubMed ID: 17240841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A consistent chromosome abnormality involving "E" group chromosome in acute leukaemias.
    Khare AG; Advani SH; Bhisey AN; Ranadive KJ
    Indian J Cancer; 1977 Mar; 14(1):81-6. PubMed ID: 885573
    [No Abstract]   [Full Text] [Related]  

  • 33. Chromosome alterations in individuals at risk for treatment-induced leukemia.
    Genuardi M; Zollino M; Mancini R; Neri G
    Haematologica; 1987; 72(6 Suppl):60-1. PubMed ID: 3127301
    [No Abstract]   [Full Text] [Related]  

  • 34. [The cytogenetics of hemopoietic dysplasias].
    Mamaev NN; Pavlova VA; Mamaeva SE; Ivanova IuS
    Gematol Transfuziol; 1988 Aug; 33(8):42-5. PubMed ID: 3192056
    [No Abstract]   [Full Text] [Related]  

  • 35. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation.
    Ho PJ; Gibson J; Vincent P; Joshua D
    Pathology; 1993 Jul; 25(3):297-304. PubMed ID: 8265251
    [No Abstract]   [Full Text] [Related]  

  • 36. [New developments in cancer cytogenetics].
    Pogosiants EE
    Genetika; 1981; 17(12):2087-99. PubMed ID: 7033044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Constitutional chromosome abnormalities and leukemia].
    Berger R
    Nouv Rev Fr Hematol; 1970; 10(1):99-107. PubMed ID: 4246340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.